首页> 外文期刊>JAMA: the Journal of the American Medical Association >Brachytherapy for In-Stent Restenosis A Distant Second Choice to Drug-Eluting Stent Placement
【24h】

Brachytherapy for In-Stent Restenosis A Distant Second Choice to Drug-Eluting Stent Placement

机译:支架内再狭窄的近距离放射疗法是药物洗脱支架置入的第二选择

获取原文
获取原文并翻译 | 示例
           

摘要

THE GREAIESI RECENT MECHANICAL ADVANCE IN PER-cutaneous coionaiy revasculaiization (PCR) has been the development of bate-metal stents, which compared with traditional balloon angioplasty substantially reduce angiographic restenosis and the need for repeat target vessel revascularization (TVR) Stents pro-vide a larger arterial lumen diameter immediately postpro-cedure (acute gain), although their drawback is an increased reparative response of neointimal formation (late loss) Fortunately, the net gain remains greatest with stents compared with other PCR devices#
机译:贝特金属支架的发展是近来皮腔内血管再造血管术(PCR)的最新进展,与传统的球囊血管成形术相比,它大大减少了血管造影再狭窄,并且需要重复进行靶血管血运重建(TVR)支架手术后立即增大动脉腔直径(急性增高),尽管其缺点是新内膜形成的修复反应增加(晚期丢失)。幸运的是,与其他PCR装置相比,支架的净增幅仍然最大#

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号